Navigation Links
3-V Biosciences Commences Patient Dosing in Phase 1 Clinical Study of FASN Inhibitor TVB-2640 in Patients with Advanced Solid Tumors
Date:12/4/2013

>.

Contact Information

Merdad Parsey, M.D., Ph.D.
Chief Executive Officer
650-561-8600

Media Inquiries

BCC Partners on behalf of 3-V Biosciences, Inc.
Karen L. Bergman
650-575-1509
kbergman@bccpartners.com
Michelle Corral
415-794-8662
mcorral@bccpartners.com


'/>"/>
SOURCE 3-V Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ambit Biosciences Provides Regulatory Update Following FDA Meeting Regarding Quizartinib (AC220)
2. Neodyne Biosciences Announces Issuance of U.S. Patent for Devices and Methods for Dressing Applicators
3. ARMO BioSciences Initiates Phase 1 Clinical Trial of First-In-Class Cancer Immunotherapy
4. 3-V Biosciences Names Dr. William McCulloch Chief Medical Officer
5. Lilly Statement on Contribution to Indiana Biosciences Research Institute
6. Indiana Biosciences Research Institute Hits $50 Million Start-Up Funding Goal
7. Regado Biosciences, Inc. Adds Global Pharmaceutical Business Veteran to Board of Directors
8. Pressure BioSciences, Inc. Discusses Record Third Quarter Revenue, Strong Fourth Quarter Guidance, Significant Progress on New Instrument Systems, and Expectation to Pay-Off All Outstanding Convertible Notes at the SeeThruEquity Financial Conference
9. Regado Biosciences, Inc. Announces Third Quarter 2013 Results
10. ViGene Biosciences Introduces Worlds Largest Collection of Pre-Made Human Full-Length cDNA ORF and miRNA Adenoviruses
11. Sangamo BioSciences Presents Clinical Data From SB-728-T HIV Study Demonstrating Long-Term Immune Reconstitution and Reduction in the HIV DNA Reservoir In Subjects with Long-Term Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015 Moerae Matrix, a clinical ... that target inflammation and fibrosis, today announced the ... as Chief Medical Officer. Dr. ... and programs, which include a pipeline of therapies ... conditions.  Bill is an accomplished strategist and scientist ...
(Date:7/6/2015)... DUBLIN and SOUTH SAN FRANCISCO, ... plc (NYSE: AGN ), a leading global pharmaceutical ... on developing novel treatments for dry eye disease, today ... which Allergan will acquire Oculeve in an all-cash transaction. ... Oculeve for a $125 million upfront payment and commercialization ...
(Date:7/5/2015)... Nihon University is pleased to announce ... Collaboration "Medicine Definitely Jumps Up with 8K" will ... Tokyo, Japan . Many experts on ... present their achievements and future prospects on progress ... with 8K technology. (Documentation: http://prw.kyodonews.jp/prwfile/release/M000079/201507031722/_prw_OA1fl_Xy4Q5W4x.pdf ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3
... CHENGDU, China , June 28 ... biopharmaceutical company that specializes,in patented biopharmaceutical, modernized traditional Chinese ... product portfolio at,the 45th 2010 National New Special Drugs ... 8th , till July 10th . Tianyin,s portfolio ...
... SAN DIEGO , June 28 ADVENTRX Pharmaceuticals, ... added to the Russell Microcap® Index on June 25, 2010 , ... , , ... available only to companies listed on a national exchange, is consistent with ...
Cached Medicine Technology:Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing 2Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing 3ADVENTRX Added to Russell Microcap Index 2
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now ... patients. Kybella is a non-surgical method to dissolve fat cells and is ... to severe fat deposits under the chin, commonly known as a double chin. Dr. ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... R. Carlson finished his 100th case using SpineFrontier’s® PedFuse® REmind® Screws. The operation ... in Newport News, VA. The procedure was an L5-S1 posterior lumbar interbody fusion ...
(Date:7/6/2015)... ... July 06, 2015 , ... Thanks to donations and a generous ... the Music & Memory Certification for hospice patients and adult day center participants. , ... only to patients but also to their families and volunteers. Music & Memory is ...
(Date:7/5/2015)... , ... July 06, 2015 , ... ... benefits market, is excited to announce the next generation of PrimeStar Individual Dental ... plans to now include two network options—Maximum Allowable Charge (MAC) and usual, customary ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women's Excellence in ... in Lake Orion. These classes are geared towards families that want their children ... break. , The fitness class will take place TUESDAYS at 4:30pm. Questions? ...
Breaking Medicine News(10 mins):Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... The doctors in North Karnataka, cautioned by the health ... compassion, and not to harass them. // ... would take action against doctors harassing and denying treatment ... inauguration of the first anniversary celebration of ‘Ashodaya’, which ...
... Ireland are about to launch a new vaccination ... of meningitis. //The vaccination against pneumococcal meningitis will ... ,"Pneumococcal meningitis is very serious," Diane ... "Children can effectively die or be left with ...
... The nitrogen-containing compounds that food producers use to cure meats ... lungs, says a new study. // ,Previous studies have ... latest study by Graham Barr at Columbia University Medical Center ... show the affect on lung function in humans, reported the ...
... Haikerwal, today urged all Australians to think about organ ... to donate organs.// ,Research published in the latest ... transplant are harvested from only a fraction of the ... that, in many instances, organs are not donated because ...
... A recent research revealed that the number of women ... a period of 5 years.// Hence, overweight women are ... ,Diabetes Australia-NSW has given shocking statistics. According to it, ... last year, whereas, only 4286 cases were reported in ...
... According to the experts at the American Academy of Allergy, ... mouth, after eating fresh fruits or vegetables//, during this part ... ,Allergens like ragweed, which begins to bloom in ... released from ragweed is the airborne allergen most responsible for ...
Cached Medicine News:Health News:Action Against Doctors Harassing HIV/AIDS Patients 2Health News:AMA Urges Organ Donors to Speak Up 2
... The pharmaceutical subset of the ... 21 of the Code of ... and final rules published in ... updated regularly as released by ...
... measuring principle - Pupil Zone Imaging Method ... offers high accuracy and reliability in refraction ... measurement (3.3 mm) using a mire ring, ... 4 points, both of which offer reliable ...
The combination of new measuring principle - Pupil Zone Imaging Method - and unique technology - SLD - offers high accuracy and reliability in refraction measurement....
... The ISI Free-Standing upper extremity table ... and in-office procedures. This table features ... and an extra-durable, hour-glass shaped Lexan ... stable -- this table is our ...
Medicine Products: